|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
U.S. Environmental Protection Agency, Research Triangle Park, North Carolina 27711
Prochloraz (PZ) is an imidazole fungicide that displays multiple endocrine activities. It inhibits steroid synthesis via P450 modulation and acts as an androgen receptor (AR) antagonist, but its effects on male sexual differentiation have not been described. The purpose of the current study was to expand in vitro observations and to determine whether PZ affected sexual differentiation. PZ effects on AR-mediated gene expression were tested using a cell line (MDA-kb2) containing endogenous AR and stably transfected with an MMTV-luc reporter. PZ concentrations greater than 1 µM caused a dose-dependent inhibition of dihydrotestosterone-induced gene expression. PZ also inhibited R1881 binding to the rat AR (IC50
60 µM). In vivo, pregnant rats received PZ by gavage from Gestational Day 14 to 18 at doses of 31.25, 62.5, 125, and 250 mg/kg of body weight per day. PZ delayed delivery in a dose-dependent manner and resulted in pup mortalities at the two highest doses. In male offspring, anogenital distance and body weight were slightly reduced at 3 days of age. Additionally, female-like areolas were observed at 13 days of age at frequencies of 31%, 43%, 41%, and 71% in the lowest-dose to highest-dose groups, respectively. Weights of androgen-dependent tissues showed dose-dependent reductions. Hypospadias and vaginal pouches were noted in all males treated with 250 mg/kg, whereas those defects were observed in 12.5% and 6.25%, respectively, of males treated with 125 mg/kg. Treatment did not affect age of preputial separation in animals without penile malformations. Despite severe malformations in males, no malformations were noted in females. Together, these results indicate that PZ alters sexual differentiation in an antiandrogenic manner.
antiandrogen, environment, fungicide, hypospadias, male reproductive tract, parturition, penis, prochloraz, sexual differentiation, toxicology
2 Correspondence: Nigel Noriega, Endocrinology Branch, MD-72, RTD, NHEERL, ORD, U.S. Environmental Protection Agency, Research Triangle Park, NC 27711. FAX: 919 541 4017; noriega.nigel{at}epa.gov
This article has been cited by other articles:
![]() |
A. K. Hotchkiss, C. V. Rider, C. R. Blystone, V. S. Wilson, P. C. Hartig, G. T. Ankley, P. M. Foster, C. L. Gray, and L. E. Gray Fifteen Years after "Wingspread"--Environmental Endocrine Disrupters and Human and Wildlife Health: Where We are Today and Where We Need to Go Toxicol. Sci., October 1, 2008; 105(2): 235 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Taxvig, U. Hass, M. Axelstad, M. Dalgaard, J. Boberg, H. R. Andeasen, and A. M. Vinggaard Endocrine-Disrupting Activities In Vivo of the Fungicides Tebuconazole and Epoxiconazole Toxicol. Sci., December 1, 2007; 100(2): 464 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Blystone, C. S. Lambright, K. L. Howdeshell, J. Furr, R. M. Sternberg, B. C. Butterworth, E. J. Durhan, E. A. Makynen, G. T. Ankley, V. S. Wilson, et al. Sensitivity of Fetal Rat Testicular Steroidogenesis to Maternal Prochloraz Exposure and the Underlying Mechanism of Inhibition Toxicol. Sci., June 1, 2007; 97(2): 512 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Blystone, J. Furr, C. S. Lambright, K. L. Howdeshell, B. C. Ryan, V. S. Wilson, G. A. LeBlanc, and L. E. Gray Jr Prochloraz Inhibits Testosterone Production at Dosages below Those that Affect Androgen-Dependent Organ Weights or the Onset of Puberty in the Male Sprague Dawley Rat Toxicol. Sci., May 1, 2007; 97(1): 65 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Aksglaede, A. Juul, H. Leffers, N. E. Skakkebaek, and A.-M. Andersson The sensitivity of the child to sex steroids: possible impact of exogenous estrogens Hum. Reprod. Update, July 1, 2006; 12(4): 341 - 349. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |